(Q28213616)

1

0 references

Ivan Mattioli

2

0 references

Jiang-Hong Gong

3

0 references

Pius Loetscher

Journal of Biological Chemistry

4

0 references

language of work or name

English

0 references

publication date

3 January 2003

0 references

published in

0 references

volume

278

0 references

issue

1

0 references

page(s)

289-95

0 references

cites work

Lymphocyte traffic control by chemokines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

The role of chemokine receptors in primary, effector, and memory immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

T-Cell Function and Migration — Two Sides of the Same Coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

HuMig: a new human member of the chemokine family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Human chemokines: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Requirement of the chemokine receptor CXCR3 for acute allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Donor-derived IP-10 initiates development of acute allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

RANTES and MCP-3 antagonists bind multiple chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Human Mig chemokine: biochemical and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Structure, function, and inhibition of chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Blocking chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Endocytosis and recycling of G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

CCR5 is characteristic of Th1 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200

HIV blocked by chemokine antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209470200